TapewireFind a company

person · Reporting owner

Westfall Nicholas Michael

Disclosed activity across 1 company

Tapewire entity
67670
SEC CIK
0001676780

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

CHEMED CORP

Report date February 05, 2026 · Filed February 05, 2026

Section 16 reporting ended · disclosed 2026-02-05. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
August 04, 2025 Filed Aug 5, 2025 14:30 UTC CHEMED CORP CHE · Entity 3723 SaleCapital Stock 10,012 $421.91 $4,224,162.92
Disclosure

SEC source: 0000950170-25-102520 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.00 to $426.16. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

Read SEC document
May 09, 2025 Filed May 12, 2025 18:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative 9,956 $462.04 Strike: $462.04 $4,600,070.24
Disclosure

SEC source: 0000950170-25-069033 · ownership.xml · derivative · entry 5

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,172

Underlying: Capital Stock · 9,956 shares

Expires 2027-10-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/31/2023

Read SEC document
May 09, 2025 Filed May 12, 2025 18:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative 16,132 $445.35 Strike: $445.35 $7,184,386.20
Disclosure

SEC source: 0000950170-25-069033 · ownership.xml · derivative · entry 4

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,128

Underlying: Capital Stock · 16,132 shares

Expires 2026-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/28/2022.

Read SEC document
May 09, 2025 Filed May 12, 2025 18:42 UTC CHEMED CORP CHE · Entity 3723 Tax withholdingCapital Stock 23,000 $569.70 $13,103,100.00
Disclosure

SEC source: 0000950170-25-069033 · ownership.xml · nonDerivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,012

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

Read SEC document
May 09, 2025 Filed May 12, 2025 18:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 9,956 $462.04 $4,600,070.24
Disclosure

SEC source: 0000950170-25-069033 · ownership.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,012

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 09, 2025 Filed May 12, 2025 18:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 16,132 $445.35 $7,184,386.20
Disclosure

SEC source: 0000950170-25-069033 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,056

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:05 UTC CHEMED CORP CHE · Entity 3723 GrantPerformance Stock Units · Derivative 1,264 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-022439 · ownership.xml · derivative · entry 6

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,384

Underlying: Capital Stock · 1,264 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter.

F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2025 to December 31, 2027. The determination of the performance level is to be made by March 15, 2028 and earned shares to be delivered thereafter.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:05 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionPerformance Stock Units · Derivative 560 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-022439 · ownership.xml · derivative · entry 5

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,120

Underlying: Capital Stock · 560 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025.

F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:05 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionPerformance Stock Units · Derivative 560 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-022439 · ownership.xml · derivative · entry 4

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,680

Underlying: Capital Stock · 560 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025.

F5 · derivative.expiration_date: PSUs awarded February 18, 2022 vest based on achievement of performance targets over a period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:05 UTC CHEMED CORP CHE · Entity 3723 Tax withholdingCapital Stock 658 $553.39 $364,130.62
Disclosure

SEC source: 0000950170-25-022439 · ownership.xml · nonDerivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,924

F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:05 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 342 $553.39 $189,259.38
Disclosure

SEC source: 0000950170-25-022439 · ownership.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,582

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2022 through December 31, 2024, compared to a defined peer group of companies. The Company's performance ranked in the 31.3 percentile of that group, yielding an award of 60.4%; including the reinvestment of dividends paid during such period, the award is 61.0% of target.

Read SEC document
February 14, 2025 Filed Feb 18, 2025 22:05 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 1,131 $553.39 $625,884.09
Disclosure

SEC source: 0000950170-25-022439 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,240

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The number of performace stock units ("PSUs") that vested was based on the Company's cumulative adjusted earnings per share for the period January 1, 2022 through December 31, 2024. The actual performance of $64.97 exceeded the maximum payout threshold of $63.75 and therefore yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target.

Read SEC document
October 22, 2024 Filed Oct 23, 2024 18:40 UTC CHEMED CORP CHE · Entity 3723 GrantStock Option (right to buy with tandem tax withholding) · Derivative 16,788 $597.70 Strike: $597.70 $10,034,187.60
Disclosure

SEC source: 0000950170-24-116574 · ownership.xml · derivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,260

Underlying: Capital Stock · 16,788 shares

Expires 2029-10-22

F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/22/2025

Read SEC document
September 09, 2024 Filed Sep 10, 2024 15:14 UTC CHEMED CORP CHE · Entity 3723 SaleCapital Stock 1,713 $569.35 $975,296.55
Disclosure

SEC source: 0000950170-24-104958 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,109

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $568.09 to $571.895. The reporting person undertakes to provide Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

Read SEC document
September 04, 2024 Filed Sep 6, 2024 14:20 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionStock Option (right to buy with tandem tax withholding) · Derivative 15,333 $471.74 Strike: $471.74 $7,233,189.42
Disclosure

SEC source: 0000950170-24-104251 · ownership.xml · derivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,472

Underlying: Capital Stock · 15,333 shares

Expires 2025-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2021

Read SEC document
September 04, 2024 Filed Sep 6, 2024 14:20 UTC CHEMED CORP CHE · Entity 3723 Tax withholdingCapital Stock 13,620 $586.39 $7,986,631.80
Disclosure

SEC source: 0000950170-24-104251 · ownership.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,822

F1 · kind: Payment of purchase price and tax obligation on stock option exercise.

Read SEC document
September 04, 2024 Filed Sep 6, 2024 14:20 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 15,333 $471.74 $7,233,189.42
Disclosure

SEC source: 0000950170-24-104251 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 30, 2024 Filed Jul 31, 2024 14:49 UTC CHEMED CORP CHE · Entity 3723 SaleCapital Stock 2,000 $561.58 $1,123,160.00
Disclosure

SEC source: 0000950170-24-088299 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,990

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.55 to $562.14. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate prce within the ranges set forth in footnote (1) of this Form 4.

Read SEC document
July 30, 2024 Filed Aug 1, 2024 19:17 UTC Amendment CHEMED CORP CHE · Entity 3723 SaleCapital Stock 2,000 $561.58 $1,123,160.00
Disclosure

SEC source: 0000950170-24-089186 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,109

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $561.55 to $562.14. The reporting person undertakes to provide Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

F2 · balance_after: Amended filing due to administrative error

Read SEC document
February 16, 2024 Filed Feb 20, 2024 20:12 UTC CHEMED CORP CHE · Entity 3723 GrantPerformance Share Units · Derivative 1,066 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-017002 · ownership.xml · derivative · entry 6

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,240

Underlying: Capital Stock · 1,066 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Chemed Capital Stock.

F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter.

F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2024 to December 31, 2026. The determination of the performance level is to be made by March 15, 2027 and earned shares to be delivered thereafter.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 20:12 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionPerformance Share Units · Derivative 504 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-017002 · ownership.xml · derivative · entry 5

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,174

Underlying: Capital Stock · 504 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024.

F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 20:12 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionPerformance Share Units · Derivative 504 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-017002 · ownership.xml · derivative · entry 4

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,678

Underlying: Capital Stock · 504 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024.

F5 · derivative.expiration_date: PSUs awarded February 19, 2021 vest based on achievement of performance targets over a period of January 1, 2021 through December 31, 2023. The determination of the performance level was to be made by March 15, 2024.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 20:12 UTC CHEMED CORP CHE · Entity 3723 Tax withholdingCapital Stock 352 $586.49 $206,444.48
Disclosure

SEC source: 0000950170-24-017002 · ownership.xml · nonDerivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,109

F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 20:12 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 471 $586.49 $276,236.79
Disclosure

SEC source: 0000950170-24-017002 · ownership.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,461

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2021 through December 31, 2023 compared to a defined peer group of companies. The Company's performance ranked in the 47th percentile of that group, yielding an award of 92.6%; including the reinvestment of dividends paid during such period, the award is 93.4% of target.

Read SEC document
February 16, 2024 Filed Feb 20, 2024 20:12 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionCapital Stock 314 $586.49 $184,157.86
Disclosure

SEC source: 0000950170-24-017002 · ownership.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,990

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2021 through December 31, 2023. The actual performance of 5.47% yielded an award of 61.7% of target; including the reinvestment of dividends paid during such period, the award is 62.2% of target.

Read SEC document
October 25, 2023 Filed Oct 26, 2023 16:46 UTC CHEMED CORP CHE · Entity 3723 Grantstock option(right to buy with tandem tax withholding) · Derivative 14,406 $509.46 Strike: $509.46 $7,339,280.76
Disclosure

SEC source: 0001209191-23-053619 · doc4.xml · derivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,805

Underlying: capital stock · 14,406 shares

Expires 2028-10-25

F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/25/2024.

Read SEC document
June 01, 2023 Filed Jun 1, 2023 18:36 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative 1,330 $413.19 Strike: $413.19 $549,542.70
Disclosure

SEC source: 0001209191-23-033282 · doc4.xml · derivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,069

Underlying: capital stock · 1,330 shares

Expires 2024-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020

Read SEC document
June 01, 2023 Filed Jun 1, 2023 18:36 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 1,330 $413.19 $549,542.70
Disclosure

SEC source: 0001209191-23-033282 · doc4.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.00 to $540.71. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 19:10 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative 12,670 $413.19 Strike: $413.19 $5,235,117.30
Disclosure

SEC source: 0001209191-23-034208 · doc4.xml · derivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,399

Underlying: capital stock · 12,670 shares

Expires 2024-10-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/29/2020

Read SEC document
June 01, 2023 Filed Jun 5, 2023 19:10 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 12,670 $533.70 $6,761,979.00
Disclosure

SEC source: 0001209191-23-034208 · doc4.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,676

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.00 to $535.34. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 19:10 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 12,670 $413.19 $5,235,117.30
Disclosure

SEC source: 0001209191-23-034208 · doc4.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 30, 2023 Filed Jun 1, 2023 18:36 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 1,330 $540.34 $718,652.20
Disclosure

SEC source: 0001209191-23-033282 · doc4.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,346

Read SEC document
February 17, 2023 Filed Feb 22, 2023 20:10 UTC CHEMED CORP CHE · Entity 3723 Grantperformance stock units · Derivative 1,054 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011572 · doc4.xml · derivative · entry 6

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,182

Underlying: capital stock · 1,054 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

F7 · derivative.exercise_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter.

F7 · derivative.expiration_date: Performance share units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2023 to December 31, 2025. The determination of the performance level is to be made by March 15, 2026 and earned shares to be delivered thereafter.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 20:10 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionperformance stock units · Derivative 386 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011572 · doc4.xml · derivative · entry 5

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,128

Underlying: capital stock · 386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023.

F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 20:10 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionperformance stock units · Derivative 386 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-011572 · doc4.xml · derivative · entry 4

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,514

Underlying: capital stock · 386 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSUs were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023.

F5 · derivative.expiration_date: PSUs awarded February 21, 2020 vest based on achievement of performance targets over a period of January 1, 2020 to December 31, 2022. The determination of the performance level was to be made by March 15, 2023.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 20:10 UTC CHEMED CORP CHE · Entity 3723 Tax withholdingcapital stock 548 $515.12 $282,285.76
Disclosure

SEC source: 0001209191-23-011572 · doc4.xml · nonDerivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,676

F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSUs.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 20:10 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 444 $515.12 $228,713.28
Disclosure

SEC source: 0001209191-23-011572 · doc4.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The number of PSUs that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2020 through December 31, 2022, compared to a defined peer group of companies. The Company's performance ranked in the 55.6th percentile of that group, yielding an award of 113.89%; including the reinvestment of dividends paid during such period, the award is 115% of target.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 20:10 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 780 $515.12 $401,793.60
Disclosure

SEC source: 0001209191-23-011572 · doc4.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,780

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The number of performance share units ("PSUs") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2020 through December 31, 2022. The actual performance of 12.67% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202% of target.

Read SEC document
November 03, 2022 Filed Nov 4, 2022 19:15 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative 13,500 $306.70 Strike: $306.70 $4,140,450.00
Disclosure

SEC source: 0001209191-22-055763 · doc4.xml · derivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,399

Underlying: capital stock · 13,500 shares

Expires 2023-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/2/2019

Read SEC document
November 03, 2022 Filed Nov 4, 2022 19:15 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 13,500 $477.19 $6,442,065.00
Disclosure

SEC source: 0001209191-22-055763 · doc4.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $475.00 to $483.81. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
November 03, 2022 Filed Nov 4, 2022 19:15 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 13,500 $306.70 $4,140,450.00
Disclosure

SEC source: 0001209191-22-055763 · doc4.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 14:51 UTC CHEMED CORP CHE · Entity 3723 Grantstock option(right to buy with tandem tax withholding) · Derivative 14,934 $462.04 Strike: $462.04 $6,900,105.36
Disclosure

SEC source: 0001209191-22-055186 · doc4.xml · derivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,899

Underlying: capital stock · 14,934 shares

Expires 2027-10-31

F1 · derivative.exercise_date: Vesting in three equal annual installments commencing 10/31/2023

Read SEC document
May 10, 2022 Filed May 11, 2022 15:23 UTC CHEMED CORP CHE · Entity 3723 Salecapital stock 1,432 $500.10 $716,143.20
Disclosure

SEC source: 0001209191-22-028216 · doc4.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $499.94 to $500.80. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 16:42 UTC CHEMED CORP CHE · Entity 3723 Grantperformance stock units · Derivative 1,120 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012056 · doc4.xml · derivative · entry 6

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,900

Underlying: capital stock · 1,120 shares

Expires not disclosed

F6 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock

F7 · derivative.exercise_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter.

F7 · derivative.expiration_date: Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2022 to December 31, 2024. The determination of the performance level is to be made by March 15, 2025 and earned shares to be delivered thereafter.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 16:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionperformance stock units · Derivative 477 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012056 · doc4.xml · derivative · entry 5

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,780

Underlying: capital stock · 477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022.

F5 · derivative.expiration_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 16:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionperformance stock units · Derivative 477 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-012056 · doc4.xml · derivative · entry 4

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,257

Underlying: capital stock · 477 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each PSU reflects the contingent right to receive a variable number of shares of capital stock based on achieving performance goals. PSU's were settled in shares on their scheduled vesting date as determined by the Compensation Committee.

F5 · derivative.exercise_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022.

F5 · derivative.expiration_date: PSU's awarded February 22, 2019 vest based on achievement of performance targets over a period of January 1, 2019 to December 31, 2021. The determination of the performance level was to be made by March 15, 2022.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 16:42 UTC CHEMED CORP CHE · Entity 3723 Tax withholdingcapital stock 638 $459.77 $293,333.26
Disclosure

SEC source: 0001209191-22-012056 · doc4.xml · nonDerivative · entry 3

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,432

F3 · shares: Shares withheld to satisfy tax obligations in connection with vesting of PSU's.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 16:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 628 $459.77 $288,735.56
Disclosure

SEC source: 0001209191-22-012056 · doc4.xml · nonDerivative · entry 2

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The number of PSU's that vested was based on the Company's achieving relative total shareholder returns for the period January 1, 2019 through December 31, 2021, compared to a defined peer group of companies. The Company's performance ranked in the 63rd percentile of that group, yielding an award of 130.26%; including the reinvestment of dividends paid during such period, the award is 131.6% of target.

Read SEC document
February 18, 2022 Filed Feb 23, 2022 16:42 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversioncapital stock 964 $459.77 $443,218.28
Disclosure

SEC source: 0001209191-22-012056 · doc4.xml · nonDerivative · entry 1

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The number of performance share units ("PSU's") that vested was based on the Company's achieving adjusted earnings per share growth rate for the period January 1, 2019 through December 31, 2021. The actual performance of 18.63% yielded an award of 200% of target; including the reinvestment of dividends paid during such period, the award is 202.0% of target.

Read SEC document
November 04, 2021 Filed Nov 5, 2021 15:15 UTC CHEMED CORP CHE · Entity 3723 Exercise / conversionstock option(right to buy with tandem tax withholding) · Derivative 4,176 $231.91 Strike: $231.91 $968,456.16
Disclosure

SEC source: 0001209191-21-063053 · doc4.xml · derivative · entry 6

Westfall Nicholas Michael · CIK 0001676780 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,965

Underlying: capital stock · 4,176 shares

Expires 2022-11-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Vesting in three equal annual installments commencing 11/03/2018

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.